• Skip to primary navigation
  • Skip to main content
  • Skip to footer
United Health Products Inc Logo

United Health Products, Inc.

Innovative health products for the management of complicated bleeds.

  • Home
  • About
    • Leadership
    • Code of Ethics
  • Products
  • Careers
  • Investors
  • News
    • Press Releases
  • Contact

United Health Products Issues Progress Report

March 20, 2020

HENDERSON, Nev.–(BUSINESS WIRE)–United Health Products, Inc. (OTC: UEEC) (UHP or the company) today announced that it is proceeding with its Premarket Approval (PMA) application for Class III approval to the FDA for HemoStyp®. In this current difficult environment, UHP has been working continuously with the FDA to advance its application, and has been working towards commercialization in anticipation of FDA approval.

Separately, the company announced that it is progressing in its negotiations with well positioned candidates interested in acquisition of the company or partnerships that allow penetration into the surgical markets.

About United Health Products

United Health Products develops technology; manufactures and markets patented hemostatic products for the healthcare and wound care sectors. The product, HemoStyp, is derived from oxidized regenerated cellulose. HemoStyp is an all-natural product designed to control bleeding. UHP is focused on identifying new markets and applications for its products and expanding its current markets. UHP currently sells a suite of hemostatic products to the dental, veterinary and retail markets.

For more on United Health Products, Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipates” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contacts

Company Contact:
United Health Products, Inc.
877-358-3444

IR Contact :
PAN Consultants Ltd.
Philippe Niemetz
212-344-6464
p.niemetz@panconsultants.com

Filed Under: Press Releases

Footer

Our Locations

Corporate Headquarters
520 Fellowship Road, Suite #D-406
Mt. Laurel, NJ 08054

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy

Contact Us

General Contact
info@uhpcorp.com
475.755.1005

Follow Us

  • Email
  • YouTube
  • Legal
  • Privacy Policy

Copyright © 2025 · United Health Products, Inc. All Rights Reserved. Website by Cindy Leigh Media